Brain-Delivery of Zinc-Ions as Potential Treatment for Neurological Diseases: Mini Review.
暂无分享,去创建一个
[1] D. Mittal,et al. Therapeutic potential of N-acetyl cysteine with antioxidants (Zn and Se) supplementation against dimethylmercury toxicity in male albino rats. , 2012, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[2] W. Glazer. A new antidepressant. , 2011, Behavioral healthcare.
[3] C. Croce,et al. Zinc supplementation suppresses 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis. , 2011, Carcinogenesis.
[4] Barbara Ruozi,et al. Development of Novel Zn2+ Loaded Nanoparticles Designed for Cell-Type Targeted Drug Release in CNS Neurons: In Vitro Evidences , 2011, PloS one.
[5] L. E. Arnold,et al. Zinc for attention-deficit/hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine. , 2011, Journal of child and adolescent psychopharmacology.
[6] Michael R Kreutz,et al. Concerted action of zinc and ProSAP/Shank in synaptogenesis and synapse maturation , 2011, The EMBO journal.
[7] Tim T. Chen,et al. Knockout of Zn Transporters Zip-1 and Zip-3 Attenuates Seizure-Induced CA1 Neurodegeneration , 2011, The Journal of Neuroscience.
[8] Roberta J. Ward,et al. Brain iron metabolism and its perturbation in neurological diseases , 2011, Journal of Neural Transmission.
[9] C. Levenson,et al. Role of zinc in the development and treatment of mood disorders , 2010, Current opinion in clinical nutrition and metabolic care.
[10] Zhuo Yang,et al. Zinc ion as modulator effects on excitability and synaptic transmission in hippocampal CA1 neurons in Wistar rats , 2010, Neuroscience Research.
[11] P. Burkhard,et al. Zinc-induced copper deficiency in Wilson disease , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[12] S. Sensi,et al. Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction , 2010, Cell Death and Disease.
[13] George J. Brewer,et al. Subclinical Zinc Deficiency in Alzheimer’s Disease and Parkinson’s Disease , 2010, American journal of Alzheimer's disease and other dementias.
[14] M. Valko,et al. Metals, oxidative stress and neurodegenerative disorders , 2010, Molecular and Cellular Biochemistry.
[15] R. Wetzel,et al. Abeta(1-40) forms five distinct amyloid structures whose beta-sheet contents and fibril stabilities are correlated. , 2010, Journal of molecular biology.
[16] M. Huber,et al. Role of Zinc in the Pathogenesis of Attention-Deficit Hyperactivity Disorder , 2010, CNS drugs.
[17] N. Delibaş,et al. Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease. , 2010, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[18] Winkins Santosh,et al. Metallomic Profiling and Linkage Map Analysis of Early Parkinson's Disease: A New Insight to Aluminum Marker for the Possible Diagnosis , 2010, PloS one.
[19] W. Schaffner,et al. Zinc supplement greatly improves the condition of parkin mutant Drosophila , 2010, Biological chemistry.
[20] A. Bush,et al. Cognitive Loss in Zinc Transporter-3 Knock-Out Mice: A Phenocopy for the Synaptic and Memory Deficits of Alzheimer's Disease? , 2010, The Journal of Neuroscience.
[21] K. Yokoi,et al. Effect of zinc supplementation on mood states in young women: a pilot study , 2010, European Journal of Clinical Nutrition.
[22] R. Amani,et al. Correlation Between Dietary Zinc Intakes and Its Serum Levels with Depression Scales in Young Female Students , 2010, Biological Trace Element Research.
[23] V. Mok,et al. Serum zinc is decreased in Alzheimer’s disease and serum arsenic correlates positively with cognitive ability , 2010, BioMetals.
[24] G. Tosi,et al. Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[25] M. Cunningham,et al. Zinc: The brain's dark horse , 2009, Synapse.
[26] E. Ho,et al. Zinc deficiency affects DNA damage, oxidative stress, antioxidant defenses, and DNA repair in rats. , 2009, The Journal of nutrition.
[27] R. Mogulkoc,et al. Zinc deficiency and supplementation in ovariectomized rats: their effect on serum estrogen and progesterone levels and their relation to calcium and phosphorus. , 2009, Pakistan journal of pharmaceutical sciences.
[28] M. Ghasemi,et al. Effect of metal chelating agents on pentylenetetrazole-induced seizure threshold in cholestatic mice , 2009, Seizure.
[29] I. Módy,et al. Hippocampal zinc infusion delays the development of afterdischarges and seizures in a kindling model of epilepsy , 2009, Epilepsia.
[30] W. Bari,et al. Zinc, Manganese, Calcium, Copper, and Cadmium Level in Scalp Hair Samples of Schizophrenic Patients , 2009, Biological Trace Element Research.
[31] A. Rodrigues,et al. Interaction of zinc with antidepressants in the tail suspension test , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[32] S. Przedborski,et al. Oxidative Stress in Parkinson's Disease , 2008, Annals of the New York Academy of Sciences.
[33] Rikki S. Corniola,et al. Zinc deficiency induces depression-like symptoms in adult rats , 2008, Physiology & Behavior.
[34] N. Garcia-Cairasco,et al. Chelatable zinc modulates excitability and seizure duration in the amygdala rapid kindling model , 2008, Epilepsy Research.
[35] J. D. Robertson,et al. Serum zinc in the progression of Alzheimer's disease. , 2008, Journal of Alzheimer's disease : JAD.
[36] G. Lubec,et al. Zinc deficiency induces enhanced depression-like behaviour and altered limbic activation reversed by antidepressant treatment in mice , 2008, Amino Acids.
[37] F. Cui,et al. Regulation of zinc transporters by dietary zinc supplement in breast cancer , 2007, Molecular Biology Reports.
[38] R. Orbak,et al. Effects of zinc deficiency on oral and periodontal diseases in rats. , 2007, Journal of periodontal research.
[39] J. Sørensen,et al. Zincergic innervation of medial prefrontal cortex by basolateral projection neurons , 2007, Neuroreport.
[40] Charles P. Fontaine,et al. Release of intracellular Zn2+ in cultured neurons after brief exposure to low concentrations of exogenous nitric oxide , 2007, BioMetals.
[41] K. Tóth,et al. Extracellular chelation of zinc does not affect hippocampal excitability and seizure‐induced cell death in rats , 2007, The Journal of physiology.
[42] R. Mogulkoc,et al. Effects of zinc deficiency and supplementation on plasma leptin levels in rats , 2005, Biological Trace Element Research.
[43] P. Coyle,et al. Importance of storage conditions for the stability of zinc- and cadmium-induced metallothionein , 2001, Biological Trace Element Research.
[44] W. Klein,et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[45] C. Pfeiffer,et al. Effect of Chronic Zinc Intoxication on Copper Levels , Blood Formation and Polyamines , 2007 .
[46] E. Kandel,et al. Synaptically released zinc gates long-term potentiation in fear conditioning pathways , 2006, Proceedings of the National Academy of Sciences.
[47] E. Florek,et al. Antepartum/postpartum depressive symptoms and serum zinc and magnesium levels. , 2006, Pharmacological reports : PR.
[48] S. Parvez,et al. Impact of selenium, iron, copper and zinc in on/off Parkinson's patients on L-dopa therapy. , 2006, Journal of neural transmission. Supplementum.
[49] R. Hider,et al. The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy , 2005, British journal of pharmacology.
[50] P. Fraker,et al. Chronic Zinc Deficiency in Mice Disrupted T Cell Lymphopoiesis and Erythropoiesis While B Cell Lymphopoiesis and Myelopoiesis Were Maintained , 2005, Journal of the American College of Nutrition.
[51] G. Tosi,et al. Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[52] G. Nowak,et al. Zinc and depression. An update. , 2005, Pharmacological reports : PR.
[53] Joseph Biederman,et al. Attention-Deficit/Hyperactivity Disorder: A Selective Overview , 2005, Biological Psychiatry.
[54] A. Bush,et al. The neurobiology of zinc in health and disease , 2005, Nature Reviews Neuroscience.
[55] Fiorella Marcellini,et al. Brain, aging and neurodegeneration: Role of zinc ion availability , 2005, Progress in Neurobiology.
[56] Toshio Watanabe,et al. Zinc deficiency delays gastric ulcer healing in rats , 1995, Digestive Diseases and Sciences.
[57] Alastair M. Hosie,et al. Zn2+ Ions: Modulators of Excitatory and Inhibitory Synaptic Activity , 2004, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[58] P. Doraiswamy,et al. Metals in our minds: therapeutic implications for neurodegenerative disorders , 2004, The Lancet Neurology.
[59] D. Prough,et al. Protective effects of zinc chelation in traumatic brain injury correlate with upregulation of neuroprotective genes in rat brain , 2004, Neuroscience Letters.
[60] N. Oku,et al. Possible involvement of plasma histidine in differential brain permeability to zinc and cadmium , 2002, Biometals.
[61] A. Takeda. Zinc homeostasis and functions of zinc in the brain , 2001, Biometals.
[62] F. Ozkinay,et al. Hair zinc level in Down syndrome. , 2004, Down's syndrome, research and practice : the journal of the Sarah Duffen Centre.
[63] H. Maske. Über den topochemischen Nachweis von Zink im Ammonshorn verschiedener Säugetiere , 2004, Naturwissenschaften.
[64] Mikito Yasuzawa,et al. Selection of novel structural zinc sites from a random peptide library , 2003, FEBS letters.
[65] A. Rodrigues,et al. Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice , 2003, Behavioural Brain Research.
[66] G. Nowak,et al. Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats , 2003, Brain Research Bulletin.
[67] N. Oku,et al. Susceptibility to kainate‐induced seizures under dietary zinc deficiency , 2003, Journal of neurochemistry.
[68] S. Lippard,et al. Meeting of the minds: Metalloneurochemistry , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[69] R. Cousins,et al. Dietary zinc modulates gene expression in murine thymus: Results from a comprehensive differential display screening , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[70] W. Pardridge. Blood-brain barrier drug targeting: the future of brain drug development. , 2003, Molecular interventions.
[71] Math P. Cuajungco,et al. Zinc takes the center stage: its paradoxical role in Alzheimer’s disease , 2003, Brain Research Reviews.
[72] Yen-Chung Chang,et al. Structural role of zinc ions bound to postsynaptic densities , 2002, Journal of neurochemistry.
[73] A. Bush. Metal complexing agents as therapies for Alzheimer’s disease , 2002, Neurobiology of Aging.
[74] G. Nowak,et al. Mechanisms contributing to antidepressant zinc actions. , 2002, Polish journal of pharmacology.
[75] M. Salgueiro,et al. Zinc intake versus zinc absorption: a bioavailability factor. , 2002, Nutrition.
[76] M. Vinceti,et al. Erythrocyte zinc, copper, and copper/zinc superoxide dismutase and risk of sporadic amyotrophic lateral sclerosis: a population-based case-control study , 2002, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[77] F. Dudek,et al. Zinc and Epileptogenesis , 2001, Epilepsy currents.
[78] K. Blennow,et al. Treatment of Alzheimer’s Disease with Clioquinol , 2001, Dementia and Geriatric Cognitive Disorders.
[79] G. Nowak,et al. Antidepressant-like properties of zinc in rodent forced swim test , 2001, Brain Research Bulletin.
[80] C. Masters,et al. Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice , 2001, Neuron.
[81] R. Cousins,et al. Dietary zinc deficiency increases uroguanylin accumulation in rat kidney. , 2001, Kidney international.
[82] Xudong Huang,et al. Metal Chelation as a Potential Therapy for Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.
[83] J. Koh,et al. Zn(2+): a novel ionic mediator of neural injury in brain disease. , 2000, Trends in pharmacological sciences.
[84] G. Nowak,et al. Zinc exhibits an antidepressant-like effect in the forced swimming test in mice. , 2000, Polish journal of pharmacology.
[85] J. Coffield,et al. Supplementation with L-histidine during dietary zinc repletion improves short-term memory in zinc-restricted young adult male rats. , 2000, The Journal of nutrition.
[86] B. Lönnerdal,et al. Dietary factors influencing zinc absorption. , 2000, The Journal of nutrition.
[87] R. Palmiter,et al. Seizures and neuronal damage in mice lacking vesicular zinc , 2000, Epilepsy Research.
[88] S. Fujimoto,et al. Dietary zinc deficiency decreases glutathione S-transferase expression in the rat olfactory epithelium. , 2000, The Journal of nutrition.
[89] G. Cremaschi,et al. Zinc status and immune system relationship: a review. , 2000, Biological trace element research.
[90] T. Guilarte,et al. Divalent cations modulate N-methyl-D-aspartate receptor function at the glycine site. , 1999, The Journal of pharmacology and experimental therapeutics.
[91] C. Masters,et al. Aqueous Dissolution of Alzheimer’s Disease Aβ Amyloid Deposits by Biometal Depletion* , 1999, The Journal of Biological Chemistry.
[92] R. Palmiter,et al. Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[93] A. Schauss,et al. Evidence of functional zinc deficiency in Parkinson's disease. , 1999, Journal of alternative and complementary medicine.
[94] C. Pfeiffer,et al. ZINC AND MANGANESE IN THE SCHIZOPHRENIAS , 1999 .
[95] R. Cousins,et al. Mammalian zinc transporters. , 1998, Annual review of nutrition.
[96] D. Choi,et al. Zinc and brain injury. , 1998, Annual review of neuroscience.
[97] G. Lees,et al. Zinc Metabolism in the Brain: Relevance to Human Neurodegenerative Disorders , 1997, Neurobiology of Disease.
[98] G. Kerchner,et al. Measurement of Intracellular Free Zinc in Living Cortical Neurons: Routes of Entry , 1997, The Journal of Neuroscience.
[99] M. Tohyama,et al. Expression of Zinc Transporter Gene, ZnT-1, Is Induced after Transient Forebrain Ischemia in the Gerbil , 1997, The Journal of Neuroscience.
[100] D. Rowe,et al. Zinc transport across an in vitro blood-brain barrier model , 1997 .
[101] M. Aschner. The functional significance of brain metallothioneins , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[102] Hugh Davson,et al. Physiology of the CSF and Blood-Brain Barriers , 1996 .
[103] A. Williamson,et al. Zinc reduces dentate granule cell hyperexcitability in epileptic humans , 1995, Neuroreport.
[104] D. Atar,et al. Excitation-Transcription Coupling Mediated by Zinc Influx through Voltage-dependent Calcium Channels (*) , 1995, The Journal of Biological Chemistry.
[105] C. Masters,et al. Rapid induction of Alzheimer A beta amyloid formation by zinc. , 1994, Science.
[106] M. D. de Broe,et al. Hypozincemia in depression. , 1994, Journal of affective disorders.
[107] T. Smart,et al. Modulation of inhibitory and excitatory amino acid receptor ion channels by zinc , 1994, Progress in Neurobiology.
[108] D. Choi,et al. AMPA receptor activation potentiates zinc neurotoxicity , 1993, Neuron.
[109] L. Wiley,et al. Influence of periconceptional zinc deficiency on embryonic plasma membrane function in mice. , 1993, Teratogenesis, carcinogenesis, and mutagenesis.
[110] B. Vallee,et al. The biochemical basis of zinc physiology. , 1993, Physiological reviews.
[111] B. Vallee,et al. Active zinc binding sites of zinc metalloenzymes. , 1992, Matrix (Stuttgart, Germany). Supplement.
[112] M. Ebadi. Metallothioneins and other zinc-binding proteins in brain. , 1991, Methods in enzymology.
[113] I. McLoughlin,et al. Zinc in depressive disorder , 1990, Acta psychiatrica Scandinavica.
[114] Y. Ihara,et al. Immunocytochemical and ultrastructural studies of Pick's disease , 1990, Annals of neurology.
[115] Sareen S. Gropper,et al. Advanced Nutrition and Human Metabolism , 1990 .
[116] L. Bailey,et al. Erythrocyte metallothionein as an index of zinc status in humans. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[117] M. Itoh,et al. Effects of dietary zinc status on seizure susceptibility and hippocampal zinc content in the El (epilepsy) mouse. , 1990, Brain research.
[118] C. Frederickson. Neurobiology of zinc and zinc-containing neurons. , 1989, International review of neurobiology.
[119] W. W. Manser,et al. Trace element studies on Karachi population. Part IV: Blood copper, zinc, magnesium and lead levels in psychiatric patients with depression, mental retardation and seizure disorders. , 1989, JPMA. The Journal of the Pakistan Medical Association.
[120] H. Kawasaki,et al. Zinc content in discrete hippocampal and amygdaloid areas of the epilepsy (El) mouse and normal mice , 1988, Brain Research.
[121] P. G. Reeves,et al. Zinc deficiency in rats and angiotensin-converting enzyme activity: comparative effects on lung and testis. , 1988, The Journal of nutrition.
[122] D. Choi,et al. Zinc neurotoxicity in cortical cell culture , 1988, Neuroscience.
[123] M. Mayer,et al. Micromolar concentrations of Zn2+ antagonize NMDA and GABA responses of hippocampal neurons , 1987, Nature.
[124] D. Choi,et al. Zinc selectively blocks the action of N-methyl-D-aspartate on cortical neurons. , 1987, Science.
[125] M. Gershwin,et al. Studies of nutrition and autoimmunity. Failure of zinc deprivation to alter autoantibody production when initiated in disease-established mice. , 1987, The Journal of nutrition.
[126] F. Catalanotto,et al. Zinc in multiple sclerosis. II: Correlation with disease activity and elevated plasma membrane–bound zinc in erythrocytes from patients with multiple sclerosis , 1986, Annals of neurology.
[127] D. Choi,et al. Brief exposure to zinc is toxic to cortical neurons , 1986, Neuroscience Letters.
[128] M. Sterman,et al. Kindled seizure induction alters and is altered by zinc absorption , 1986, Brain Research.
[129] W. D. Ehmann,et al. Brain trace elements in Alzheimer's disease. , 1986, Neurotoxicology.
[130] A. Betz. Transport of ions across the blood-brain barrier. , 1986, Federation proceedings.
[131] G. A. Howell,et al. Stimulation-induced uptake and release of zinc in hippocampal slices , 1984, Nature.
[132] Shin-Ho Chung,et al. Release of endogenous Zn2+ from brain tissue during activity , 1984, Nature.
[133] Jianyi Huang,et al. Zinc‐Induced Seizures: A New Experimental Model of Epilepsy , 1983, Epilepsia.
[134] E. Braverman,et al. Zinc, the brain and behavior. , 1982, Biological psychiatry.
[135] I. Dreosti,et al. The effect of late prenatal and/or early postnatal zinc deficiency on the development and some biochemical aspects of the cerebellum and hippocampus in rats. , 1981, Life sciences.
[136] I. Dreosti,et al. High plasma zinc levels following oral dosing in rats and the incorporation of 3H-thymidine into deoxyribonucleic acid in rat fetuses. , 1981, Research communications in chemical pathology and pharmacology.
[137] R. Tissot,et al. Role of glutamate and zinc in the hippocampal lesions of Pick's disease. , 1981, Advances in biochemical psychopharmacology.
[138] G. Evans,et al. Growth Stimulating Effect of Picolinic Acid Added to Rat Diets 1 , 1980, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[139] M. Kozik,et al. Morphological and histochemical changes occurring in the brain of rats fed large doses of zinc oxide. , 1980, Folia histochemica et cytochemica.
[140] J. Jones,et al. Optimal level of zinc supplementation of young rats fed rapeseed protein concentrate. , 1979, Journal of agricultural and food chemistry.
[141] T. Hoogenraad,et al. ORAL ZINC IN WILSON'S DISEASE , 1979, The Lancet.
[142] D. R. Snyder,et al. Neurological, microscopic and enzyme-histochemical assessment of zinc pyrithione toxicity. , 1979, Food and cosmetics toxicology.
[143] R. Tissot,et al. [Pick's disease and zinc metabolism]. , 1977, Revue neurologique.
[144] B. Slavin. Fundamentals of Clinical Chemistry , 1977 .
[145] P. Czerniak,et al. Phenothiazine derivatives and brain zinc. Turnover radioactive isotope study. , 1971, Archives of neurology.
[146] J. Murphy. Intoxication following ingestion of elemental zinc. , 1970, JAMA.
[147] F. Timm. [Histochemistry of zinc]. , 1958, Deutsche Zeitschrift fur die gesamte gerichtliche Medizin.